Galuska László

1.

Opposits, G., Nagy, M., Barta, Z., Aranyi, S. C., Szabó, D., Makai, A., Varga, I., Galuska, L., Trón, L., Balkay, L., Emri, M.: Automated procedure assessing the accuracy of HRCT-PET registration applied in functional virtual bronchoscopy.
EJNMMI Res. 11 (1), 1-13, 2021.

doi DEA

Journal metrics:

Q2 Radiology, Nuclear Medicine and Imaging

2.

Varga, J., Garai, I., Barna, S., Budai, Á., Farkas, B., Galuska, L., Hascsi, Z., Mihovk, I., Mikó, M.: Nuclear Medicine: for medical students.
Debreceni Egyetemi Kiadó, Debrecen, 194 p., 2021. ISBN: 9789633189023

DEA

3.

Barna, S., Rózsa, D., Varga, J., Fodor, A., Szilasi, M., Galuska, L., Garai, I.: First comparative results about the direct effect of traditional cigarette and e-cigarette smoking on lung alveolocapillary membrane using dynamic ventilation scintigraphy.
Nucl. Med. Commun. 40 (2), 153-158, 2019.

doi DEA

Journal metrics:

Q2 Medicine (miscellaneous)

Q2 Radiology, Nuclear Medicine and Imaging

4.

Barna, S., Garai, I., Galuska, L., Nagy, E. V., Varga, J.: Quantitative retrobulbar SPECT/CT measurement in Graves' ophtalmopathy.
Eur. J. Nucl. Med. Mol. Imaging. 46 (S1), S489, 2019.

doi DEA WoS

5.

Berta, E., Bodor, M., Galuska, L., Paragh, G., Erdei, A., Gazdag, A., Ujhelyi, B., Berényi, E., Katkó, M., Gazsó, A., Nagy, E. V.: Early stage Graves' disease is uniformly accompanied by orbital immune activity even in patients who fail to develop orbithopathy during follow-up.
Exp. Clin. Endocrinol. Diabet. 126 (10), 628-631, 2018.

doi DEA

Journal metrics:

Q3 Endocrinology

Q3 Endocrinology, Diabetes and Metabolism

Q2 Internal Medicine

Q2 Medicine (miscellaneous)

6.

Varga, J., Garai, I., Barna, S., Budai, Á., Farkas, B., Galuska, L., Hascsi, Z., Mihovk, I., Mikó, M.: Nukleáris Medicina: orvostanhallgatóknak.
Debreceni Egyetemi Kiadó, Debrecen, 190 p., 2018. ISBN: 9789633187616

DEA

7.

Palatka, K., Kacska, S., Lovas, S., Garai, I., Varga, J., Galuska, L.: The potential role of FDG PET-CT in the characterization of the activity of Crohn's disease, staging follow-up and prognosis estimation: a pilot study.
Scand. J. Gastroenterol. 53 (1), 24-30, 2018.

doi DEA

Journal metrics:

Q2 Gastroenterology

8.

Galuska, L., Barna, S., Varga, J., Garai, I., Nagy, E. V.: The role of 99mTc-DTPA retrobulbar SPECT in staging and follow-up of Graves' orbitopathy.
Nucl. Med. Rev. Cent. East. Eur. 21 (1), 47-51, 2018.

doi DEA

Journal metrics:

Q3 Medicine (miscellaneous)

Q3 Radiology, Nuclear Medicine and Imaging

9.

Barna, S., Garai, I., Rózsa, D., Varga, J., Fodor, A., Szilasi, M., Galuska, L.: Comparison of cigarette and ecigarette smoking to alveolocapillary membrane by dynamic ventilation scintigraphy.
Eur. J. Nucl. Med. Mol. Imaging. 43 (Suppl.), S603-S604, 2016.

doi DEA WoS

10.

Mikó, I., Pető, K., Deák, Á., Németh, N., Ványolos, E., Furka, A., Furka, I., Nagy, T., Garai, I., Galuska, L., Varga, J.: Comparison of Three Imaging Methods for the Visualization of Splenic-Autotransplants in Large Animal Model.
Eur. Surg. Res. 57 (Suppl.), 122, 2016.

doi DEA

11.

Máté, G., Szikra, D. P., Simecek, J., Szilágyi, S., Trencsényi, G., Wester, H. J., Kertész, I., Galuska, L.: Multiparametric labeling optimization and synthesis of 68Ga-labeled compounds applying a continuous-flow microfluidic methodology.
Journal of Flow Chemistry. 6 (2), 86-93, 2016.

doi DEA

Journal metrics:

Q2 Chemistry (miscellaneous)

Q1 Fluid Flow and Transfer Processes

Q2 Organic Chemistry

12.

Garai, I., Farkas, B., Oszlánszki, A., Berczi, C., Flaskó, T., Galuska, L.: 11C-kolin-PET/CT a prosztatarák diagnosztikájában - a hazai tapasztalatok tükrében.
Magyar Onkol. 59 (1), 25-29, 2015.

DEA

Journal metrics:

Q3 Medicine (miscellaneous)

Q4 Oncology

13.

Gellén, E., Sántha, O., Janka, E. A., Juhász, I., Péter, Z., Erdei, I., Lukács, R., Fedinecz, N., Galuska, L., Remenyik, É., Emri, G.: Diagnostic accuracy of 18F-FDG-PET/CT in early and late stages of high-risk cutaneous malignant melanoma.
J. Eur. Acad. Dermatol. Venereol. 29 (10), 1938-1944, 2015.

doi DEA

Journal metrics:

D1 Dermatology

Q1 Infectious Diseases

14.

Máté, G., Kertész, I., Enyedi, K. N., Mező, G., Angyal, J., Molnárné Vasas, N., Kis, A., Szabó, É., Emri, M., Bíró, T., Galuska, L., Trencsényi, G.: In vivo imaging of Aminopeptidase N (CD13) receptors in experimental renal tumors using the novel radiotracer 68Ga-NOTA-c(NGR).
Eur. J. Pharm. Sci. 69, 61-71, 2015.

doi DEA

Journal metrics:

D1 Pharmaceutical Science

15.

Máté, G., Simecek, J., Pniok, M., Kertész, I., Notni, J., Wester, H. J., Galuska, L., Hermann, P.: The Influence of the Combination of Carboxylate and Phosphinate Pendant Arms in 1,4,7-Triazacyclononane-Based Chelators on Their 68Ga Labelling Properties.
Molecules. 20 (7), 13112-13126, 2015.

doi DEA

Journal metrics:

Q2 Analytical Chemistry

Q2 Chemistry (miscellaneous)

Q2 Drug Discovery

Q2 Medicine (miscellaneous)

Q3 Molecular Medicine

Q2 Organic Chemistry

Q2 Pharmaceutical Science

Q2 Physical and Theoretical Chemistry

16.

Berta, E., Ujhelyi, B., Szabados, L., Galuska, L., Erdei, A., Gazdag, A., Halmi, S., Nagy, E. V., Bodor, M.: There is a detectable immune activity in the orbits of all patients diagnosed with Graves' regardless of later development of Graves' orbitopathy.
Endocrine Abstracts. 37, GP, 2015.

doi DEA

17.

Erdei, A., Paragh, G., Kovács, P., Karányi, Z., Berényi, E., Galuska, L., Lenkey, Á., Szabados, L., Győry, F., Ujhelyi, B., Berta, A., Boda, J., Berta, E., Bodor, M., Gazdag, A., Nagy, E. V.: Rapid response to and long-term effectiveness of anti-CD20 antibody in conventional therapy resistant Graves' orbitopathy: a five-year follow-up study.
Autoimmunity. 47 (8), 548-555, 2014.

doi DEA

Journal metrics:

Q3 Immunology

Q3 Immunology and Allergy

18.

Pokol, E., Deim, N., Veres, I., Galuska, L., Erdei, I., Dezső, B., Péter, Z., Remenyik, É., Emri, G., Juhász, I.: Sentinel nyirokcsomó-biopszia melanoma malignumban: 10 év tapasztalatának eredményei a DEOEC Bőrgyógyászati Klinikáján = Sentinel lymph node biopsy : result of 10 years' experience at the Department of Dermatology, Medical and Health Science Center, University of Debrecen.
Bőrgyógyász. Venerol. Szle. 90 (3), 100-105, 2014.

doi DEA

19.

Máté, G., Szikra, D. P., Simecek, J., Kertész, I., Wester, H. J., Galuska, L.: Taking Ga-68 labeling optimization to the fast line with a new microfluidic system.
J. Nucl. Med. 55 (Suppl), 436, 2014.

DEA

20.

Galuska, L., Kis, S. A., Fedinecz, N., Palatka, K., Lovas, S., Garai, I., Varga, J.: The value of FDG PET-CT in Crohn's disease to assess the prognosis of planned biological therapy (P819).
Eur. J. Nucl. Med. Mol. Imaging. 41 (S2), S593, 2014.

doi DEA

21.

Balkay, L., Emri, M., Galuska, L., Garai, I., Kis, S. A., Szűcs, B., Varga, J.: Újdonságok és új lehetőségek a funkcionális képalkotásban: kvantitatív módszerek.
Magyar Onkol. 58 (4), 251-260, 2014.

DEA

Journal metrics:

Q4 Medicine (miscellaneous)

Q4 Oncology

22.

Erdei, A., Gazdag, A., Bodor, M., Berta, E., Katkó, M., Ujhelyi, B., Steiber, Z., Győry, F., Urbancsek, H., Barna, S., Galuska, L., Nagy, E. V.: Új lehetőségek az endokrin orbitopathia kezelésében.
Orvosi Hetilap. 155 (33), 1295-1300, 2014.

doi DEA

Journal metrics:

Q3 Medicine (miscellaneous)

23.

Gellén, E., Sántha, O., Remenyik, É., Juhász, I., Péter, Z., Erdei, I., Galuska, L., Emri, G.: A 18F-FDG-PET/CT diagnosztikai pontosságának összehasonlítása korai és késői stádiumú melanoma malignumban.
Bőrgyógyász. Venerol. Szle. 89 (6), 160, 2013.

DEA

24.

Galuska, L., Kis, S. A., Fedinecz, N., Palatka, K., Lovas, S., Garai, I., Varga, J.: Assessment of crohn's disease activity by FDG PET-CT (024).
Nucl. Med. Rev. Cent. E. Eur. 16 (Suppl.), A12, 2013.

DEA

25.

Galuska, L., Kis, S. A., Fedinecz, N., Palatka, K., Lovas, S., Garai, I., Varga, J.: Assessment of Crohn's disease activity by FDG PET-CT and Tc-99m HmPAO labeled white blood cell SPECT-CT in a prospective study (OP116).
Eur. J. Nucl. Med. Mol. Imaging. 40 (Supplement), S124-S125, 2013.

doi DEA

Publication list